| Title : Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes mellitus: A 24-week, multi-center, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial - Xu_2022_Diabetes.Obes.Metab__ |
| Author(s) : Xu J , Ling H , Geng J , Huang Y , Xie Y , Zheng H , Niu H , Zhang T , Yuan J , Xiao X |
| Ref : Diabetes Obes Metab , : , 2022 |
| Abstract : Xu_2022_Diabetes.Obes.Metab__ |
| ESTHER : Xu_2022_Diabetes.Obes.Metab__ |
| PubMedSearch : Xu_2022_Diabetes.Obes.Metab__ |
| PubMedID: 35791646 |
Xu J, Ling H, Geng J, Huang Y, Xie Y, Zheng H, Niu H, Zhang T, Yuan J, Xiao X (2022)
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes mellitus: A 24-week, multi-center, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial
Diabetes Obes Metab
:
Xu J, Ling H, Geng J, Huang Y, Xie Y, Zheng H, Niu H, Zhang T, Yuan J, Xiao X (2022)
Diabetes Obes Metab
: